This connection helps explain why inflammatory gastrointestinal conditions are sometimes associated with metabolic disturbances
The Need for New Formulations Because of these quite dramatic and potentially efficacious effects, and the urgency of the COVID19 pandemic, in addition to simply repurposing the original oral tablets, there have been efforts to develop new formulations and routes of administration for niclosamide, to validate them in preclinical studies, and clinically test niclosamide for COVID-19 (see this reference to clincaltrials.gov (35))
If youve tried everything and still dont feel well, this episode is packed with new paths forward
It is a place where you can rent a sailboat or paddleboat, fish, jog around, or otherwise make use of its charms
AHK-Cu (alanine-histidine-lysine copper) has some published evidence for cosmetic formulation use, but lacks GHK-Cus documented gene expression data, wound healing evidence base, and 50+ year research history
While human studies remain limited, the available animal research and anecdotal evidence suggest that BPC-157 may help: Support tendon and ligament regeneration Reduce inflammation and joint discomfort Accelerate post-cycle healing after heavy anabolic use Prevent soft-tissue injuries during high-volume training Still, athletes should be cautious: BPC-157 is not FDA-approved, and sourcing high-purity peptides from reputable suppliers is essential
